NO20070592L - Fremgangsmate for diagnostisering av prodromale former av sykdommer som er forbundet med amyloid avleiring. - Google Patents

Fremgangsmate for diagnostisering av prodromale former av sykdommer som er forbundet med amyloid avleiring.

Info

Publication number
NO20070592L
NO20070592L NO20070592A NO20070592A NO20070592L NO 20070592 L NO20070592 L NO 20070592L NO 20070592 A NO20070592 A NO 20070592A NO 20070592 A NO20070592 A NO 20070592A NO 20070592 L NO20070592 L NO 20070592L
Authority
NO
Norway
Prior art keywords
amyloid deposition
diagnosis
procedure
diseases associated
prodromal
Prior art date
Application number
NO20070592A
Other languages
English (en)
Norwegian (no)
Inventor
Jr Chester A Mathis
William E Klunk
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Publication of NO20070592L publication Critical patent/NO20070592L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20070592A 2004-07-02 2007-01-31 Fremgangsmate for diagnostisering av prodromale former av sykdommer som er forbundet med amyloid avleiring. NO20070592L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58449504P 2004-07-02 2004-07-02
PCT/US2005/023618 WO2006014382A1 (en) 2004-07-02 2005-07-01 A method of diagnosing prodromal forms of diseases associated with amyloid deposition

Publications (1)

Publication Number Publication Date
NO20070592L true NO20070592L (no) 2007-03-27

Family

ID=35058815

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070592A NO20070592L (no) 2004-07-02 2007-01-31 Fremgangsmate for diagnostisering av prodromale former av sykdommer som er forbundet med amyloid avleiring.

Country Status (11)

Country Link
US (1) US20080286202A1 (ja)
EP (1) EP1768709A1 (ja)
JP (1) JP2008505116A (ja)
CN (2) CN101060865B (ja)
AU (1) AU2005270027A1 (ja)
BR (1) BRPI0512932A (ja)
CA (1) CA2587253A1 (ja)
HK (1) HK1110218A1 (ja)
NO (1) NO20070592L (ja)
RU (1) RU2007104106A (ja)
WO (1) WO2006014382A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2427963T3 (es) 2004-07-02 2013-11-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Uso de derivados de tioflavina radiomarcados en formación de imágenes de amiloide para evaluación de las terapias antiamiloide
EP1937260A2 (en) * 2005-09-16 2008-07-02 University of Pittsburgh In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein
WO2008118122A2 (en) 2006-05-08 2008-10-02 Molecular Neuroimaging, Llc Compounds and amyloid probes thereof for therapeutic and imaging uses
JP5319121B2 (ja) 2007-01-30 2013-10-16 株式会社東芝 診療支援システム及び診療支援装置
ES2414614T3 (es) * 2007-01-30 2013-07-22 Ge Healthcare Limited Herramientas para ayudar en el diagnóstico de enfermedades neurodegenerativas
US7858803B2 (en) 2007-04-27 2010-12-28 The General Hospital Corporation Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders
BRPI0815129B8 (pt) * 2007-08-30 2021-05-25 Ge Healthcare Ltd composição radiofarmacêutica, e, métodos para preparação de uma composição radiofarmacêutica
JP2011514343A (ja) * 2008-02-27 2011-05-06 アビッド レディオファーマシューティカルズ、インク． 放射線標識ａ−ベータ結合化合物を用いたアミロイドプラークのガンマプローブ検出
JP5565647B2 (ja) * 2008-03-14 2014-08-06 よこはまティーエルオー株式会社 臓器領域特定方法、および臓器領域特定装置
CA2737028C (en) 2008-09-23 2017-06-27 Wista Laboratories Ltd. Ligands for aggregated tau molecules
JP6026089B2 (ja) * 2011-08-23 2016-11-16 東芝メディカルシステムズ株式会社 医用画像診断装置、画像情報表示装置及び制御プログラム
JP6130401B2 (ja) * 2012-01-20 2017-05-17 アンナプラガダ，アナンス 医学画像を客観的に特徴付けるための方法および組成物
WO2014195448A1 (en) * 2013-06-07 2014-12-11 Koninklijke Philips N.V. Amyloid pet brain scan quantification based on cortical profiles
CN103724207B (zh) * 2013-12-20 2016-07-06 北京智博高科生物技术有限公司 苯基苄基醚类衍生物及其制备方法和应用
GB201511846D0 (en) * 2015-07-07 2015-08-19 Ge Healthcare Ltd Beta amyloid staging
JPWO2017086303A1 (ja) * 2015-11-16 2018-09-20 キリン株式会社 ペプチド組成物およびその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874431A (en) * 1993-08-28 1999-02-23 Cancer Research Campaign Technology Limited Benzazole compounds
US6410598B1 (en) * 1994-02-03 2002-06-25 Michael P. Vitek Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
WO2002016333A2 (en) * 2000-08-24 2002-02-28 University Of Pittsburgh Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease
US7270800B2 (en) * 2000-08-24 2007-09-18 University Of Pittsburgh Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
CA2421374C (en) * 2000-09-06 2017-03-07 Aventis Pharma S.A. Methods and compositions for diseases associated with amyloidosis
TWI245764B (en) * 2001-04-23 2005-12-21 Hank F Kung Amyloid plaque aggregation inhibitors and diagnostic imaging agents
CA2474411A1 (en) * 2002-02-13 2003-08-21 Amersham Plc Benzothiazole derivatives for in vivo imaging of amyloid plaques

Also Published As

Publication number Publication date
RU2007104106A (ru) 2008-08-10
CN101060865A (zh) 2007-10-24
BRPI0512932A (pt) 2008-04-15
JP2008505116A (ja) 2008-02-21
EP1768709A1 (en) 2007-04-04
US20080286202A1 (en) 2008-11-20
CN101060865B (zh) 2011-10-05
CN102327626A (zh) 2012-01-25
WO2006014382A1 (en) 2006-02-09
AU2005270027A1 (en) 2006-02-09
CA2587253A1 (en) 2006-02-09
HK1110218A1 (en) 2008-07-11

Similar Documents

Publication Publication Date Title
NO20070592L (no) Fremgangsmate for diagnostisering av prodromale former av sykdommer som er forbundet med amyloid avleiring.
Filibian et al. In vivo imaging of glia activation using 1H‐magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity
Gomar et al. Extension and refinement of the predictive value of different classes of markers in ADNI: four-year follow-up data
Chiu et al. Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer’s disease
Petoumenos et al. Increased risk of cardiovascular disease (CVD) with age in HIV‐positive men: a comparison of the D: A: D CVD risk equation and general population CVD risk equations
Cleland et al. Covert contrast and covert errors in persistent velar fronting
Moghekar et al. Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort
CY1110252T1 (el) Μεθοδος για την προβλεψη, διαγνωση και διαφορικη διαγνωση της νοσου του αλτζχαιμερ
WO2008030973A3 (en) Methods and compositions for the detection of protein folding disorders
Connor et al. The validity of the Brief Michigan Alcohol Screening Test (bMAST) as a problem drinking severity measure
Shimomura et al. Homocysteine levels are associated with hippocampus volume in type 2 diabetic patients
Li et al. Effect of human cerebrospinal fluid sampling frequency on amyloid‐β levels
Haghshomar et al. White matter changes correlates of peripheral neuroinflammation in patients with Parkinson’s disease
WO2014052921A3 (en) Patient health record similarity measure
MX2022001817A (es) Metodos para detectar isoformas de la region de union a microtubulos (mtbr) tau y uso de las mismas.
Sun et al. Normal reference values of diastolic strain rate in healthy individuals: chronological trends and the comparison according to genders
Kovács et al. Genetically determined pattern of left ventricular function in normal and hypertensive hearts
Mirzakhanian et al. Biomarkers in psychosis: an approach to early identification and individualized treatment
Cabrera et al. Spironolactone increases serum uric acid levels in patients with chronic kidney disease
Griffo et al. Italian survey on prevalence and disease management of chronic heart failure and chronic obstructive pulmonary disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design
Aggarwal et al. Hypertrophic cardiomyopathy associated with sleep apnea: serious implications and COGENT management strategy
WO2009079977A3 (de) Verfahren zur schlafmedizinischen vorabdiagnose und therapie-begleitung
Javed et al. Using limb-lead ECGs to investigate asymptomatic atrial fibrillation in primary care
RU2018105982A (ru) Способ дифференциальной диагностики форм хронического тонзиллита с использованием раман-флюоресцентной спектроскопии
Mohd Hadi Pritam Facial creases in human identification

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application